Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies
Most Cited Paper
in Vector-borne infectious diseases
18 Months Post-Publication
Class of 2026
“Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
VLA15 · Lyme disease vaccine · dose optimization · vaccination schedule · phase 2 trial · observer-blind design · placebo-controlled study · Healthy adults · Multicentre trial · immunogenicity · safety endpoints · dose-response relationship · prime-boost regimen · antibody titers · OspA · Borrelia burgdorferi · vaccine efficacy · adverse events
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Vector-borne infectious diseases Papers, Class of 2026. https://pri.pepkio.com/top-papers/vector-borne-infectious-diseases/2026. Accessed 2026-07-31. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459